易特科(前海安测)姚育东院士调研指导“AI+医疗”

2019-06-29 11:24

2019年6月29日,易特科首席科学家、加拿大工程院姚育东院士莅临易特科集团(前海安测),研讨AI-CAD项目进展,指导AI医疗影像研发创新工作。易特科集团董事长兼CEO张贯京先生、CTO葛新科博士、MD梁艳妮女士、总工程师高伟明博士、副总工程师张红治博士、研究院唐苏明博士、研究员梁昊源博士、研究员陈琦博士等医学AI技术研发团队一同参与了交流座谈。


本次总结交流会议以“智能肺癌AI-CAD诊断”为主题,围绕项目AI-CAD研发进展、AI医学影像、图像大数据处理等话题进行了深入探讨。姚育东院士向我司研发团队讲解了他在智能肺癌AI-CAD诊断领域的最新研究成果以及智能肺癌AI-CAD诊断系统研发项目落地应用、产业化探索的新模式、新思路。同时,会议还讨论和分享了AI、大数据、5G等新服务、新技术、新模式在智慧医疗服务落地过程中的心得和成功经验,为下半年度院士团队研发工作的顺利开展奠定了坚实的基础!


张贯京董事长在总结讲话中夸赞了我司研发团队上半年度的研发创新举措、特色亮点及取得的变化、成效,他鼓励我司研发团队把讨论的结果和经验与当前工作实践有效衔接、有机结合,为今年下半年度研发工作贡献新力量、展现新作为!



Academician Yao Yudong of E-Techco (Qianhai AnyCheck) investigated and guided "AI + Medical"

On June 29th, 2019, E-Techco's chief scientist and Academician Yao Yudong of Canadian Academy of Engineering visited the E-Techco Group (Qianhai AnyCheck) to discuss the progress of AI-CAD project. Mr. Zhang Guanjing, Chairman and CEO of E-Techco Group, CTO Dr. Ge Xinke, MD Ms. Liang Yanni, Chief Engineer Dr. Gao Weiming, Deputy Chief Engineer Dr. Zhang Hongzhi, Researcher Dr. Tang Suming, Researcher Dr. Liang Haoyuan, Researcher Dr. Chen Qi, and other medical AI technology R&D team participated in the exchange discussion together.

This summary meeting discussed the topic of “Intellectual Lung Cancer AI-CAD Diagnosis” and discussed in depth the development of AI-CAD, cloud platform design, and image big data processing. Academician Yao Yudong explained to the R&D team of our company the latest research results in the field of intelligent lung cancer AI-CAD diagnosis and the new application and new ideas of the application and industrialization of intelligent lung cancer AI-CAD diagnostic system research and development project. At the same time, the conference also discussed and shared the experience and successful experience of new services, new technologies and new models in AI, big data and 5G in the process of the development of smart medical services, which laid a solid foundation for the smooth development of the academic team in the second half of the year.

In his concluding remarks, Chairman Zhang Guanjing praised the R&D and innovation initiatives, highlights, and changes and achievements of our R&D team in the first half of the year. He encouraged our R&D team to effectively link the results and experience of the discussions with current work practices. Combine and contribute new strengths and new achievements for the research and development work in the second half of this year.